Status:
TERMINATED
Acoustic Assessment of Nebulized Epinephrine Versus Albuterol for RSV Bronchiolitis- a Double Blind Study
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Rsv Bronchiolitis
Eligibility:
All Genders
Up to 1 years
Phase:
PHASE4
Brief Summary
Bronchiolitis is a common disease of infancy and a main reason for infants' hospital admissions in the first 2 years of life. The main cause of bronchiolitis is RSV (respiratory syncytial virus). Thou...
Detailed Description
Inpatient Infants younger than 2 years of age with first episode of RSV bronchiolitis will be randomly assigned to treatment with nebulized epinephrine (1 mg diluted with 3 ml of 0.9% saline) or nebul...
Eligibility Criteria
Inclusion
- Under one year of age
- first episode of wheezing and dyspnea
- RSV antigen detected by ELISA
- parents signed informed consent.
Exclusion
- infants with chronic lung disease
- cardiac disease
- other chronic conditions.
Key Trial Info
Start Date :
December 1 2000
Trial Type :
INTERVENTIONAL
End Date :
May 1 2001
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00361452
Start Date
December 1 2000
End Date
May 1 2001
Last Update
August 8 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Ward, Rambam Medical Centre
Haifa, Israel, 31096